Effect of sulfonylureas on switching to insulin therapy (twice-daily biphasic insulin aspart 30): Comparison of twice-daily biphasic insulin aspart 30 with or without glimepiride in type 2 diabetic patients poorly controlled with sub-maximal glimepiride

Autor: Ebato, C., Shimizu, T., Arakawa, M., Mita, T., Fujitani, Y., Watada, H., Kawamori, R., Hirose, T.
Zdroj: In Diabetes Research and Clinical Practice 2009 86(1):31-36
Databáze: ScienceDirect